0001171843-18-004991.txt : 20180703 0001171843-18-004991.hdr.sgml : 20180703 20180703082418 ACCESSION NUMBER: 0001171843-18-004991 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180629 FILED AS OF DATE: 20180703 DATE AS OF CHANGE: 20180703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Toner E. Scott CENTRAL INDEX KEY: 0001643772 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36694 FILM NUMBER: 18934743 MAIL ADDRESS: STREET 1: 25 PIER 7 CITY: CHARLESTOWN STATE: MA ZIP: 02129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-890-0102 MAIL ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 ownership.xml X0306 4 2018-06-29 0 0001359931 PROTEON THERAPEUTICS INC PRTO 0001643772 Toner E. Scott C/O PROTEON THERAPEUTICS 200 WEST STREET WALTHAM MA 02451 0 1 0 0 Senior VP of Commercial Common Stock 2018-06-29 5 A 0 E 4856 1.615 A 19240 D The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of January 1, 2018 through June 30, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). /s/ George A. Eldridge as attorney-in-fact 2018-07-03